Within the medical trial experience with Xyrem in narcolepsy/cataplexy sufferers at therapeutic doses, two sufferers described anxiousness and just one described sleeplessness next abrupt discontinuation with the termination of the medical trial; in The 2 patients with stress, the frequency of cataplexy experienced improved markedly simultaneously.